Literature DB >> 33815847

Zero-Contrast Left Main Bifurcation PCI in an Elderly Patient with Chronic Kidney Disease.

Prathap Kumar1, Stalin Roy1, Blessvin Jino1, Manu Rajendran1, Sandheep G Villoth1.   

Abstract

Patients with chronic kidney disease develop acute kidney injury (AKI) following percutaneous coronary intervention (PCI). We report a case highlighting the benefits of zero-contrast left main bifurcation PCI in an 82-year-old male with non-ST elevation myocardial infarction and contrast-induced AKI following coronary angiography. The patient was on routine follow-up, and he was stable and asymptomatic at nine months follow-up.
Copyright © 2021 Prathap Kumar et al.

Entities:  

Year:  2021        PMID: 33815847      PMCID: PMC7990558          DOI: 10.1155/2021/6658992

Source DB:  PubMed          Journal:  Case Rep Cardiol        ISSN: 2090-6404


  11 in total

1.  “Sepal wire technique”--a novel technique for aorto-ostial left main stenting.

Authors:  Chi Kin Chan; Raymond Cy Fung
Journal:  J Invasive Cardiol       Date:  2011-05       Impact factor: 2.022

2.  Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study.

Authors:  Ziad A Ali; Keyvan Karimi Galougahi; Tamim Nazif; Akiko Maehara; Mark A Hardy; David J Cohen; Lloyd E Ratner; Michael B Collins; Jeffrey W Moses; Ajay J Kirtane; Gregg W Stone; Dimitri Karmpaliotis; Martin B Leon
Journal:  Eur Heart J       Date:  2016-03-07       Impact factor: 29.983

3.  Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?

Authors:  Jeremiah R Brown; John F Robb; Clay A Block; Anton C Schoolwerth; Aaron V Kaplan; Gerald T O'Connor; Richard J Solomon; David J Malenka
Journal:  Circ Cardiovasc Interv       Date:  2010-06-29       Impact factor: 6.546

4.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.

Authors:  R G Cigarroa; R A Lange; R H Williams; L D Hillis
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

5.  Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.

Authors:  Eugenia Nikolsky; Roxana Mehran; Diane Turcot; Eve D Aymong; Gary S Mintz; Zoran Lasic; Alexandra J Lansky; Emmanouil Tsounias; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George D Dangas
Journal:  Am J Cardiol       Date:  2004-08-01       Impact factor: 2.778

6.  Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.

Authors:  Warren K Laskey; Charles Jenkins; Faith Selzer; Oscar C Marroquin; Robert L Wilensky; Ruchira Glaser; Howard A Cohen; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

7.  Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club.

Authors:  Francesco Burzotta; Jens Flensted Lassen; Thierry Lefèvre; Adrian P Banning; Yiannis S Chatzizisis; Thomas William Johnson; Miroslaw Ferenc; Sudhir Rathore; Remo Albiero; Manuel Pan; Olivier Darremont; David Hildick-Smith; Alaide Chieffo; Marco Zimarino; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2021-03-19       Impact factor: 6.534

8.  Zero contrast retrograde chronic total occlusions percutaneous coronary intervention: a case series.

Authors:  Raja Hatem; Matthew T Finn; Robert F Riley; Moses Mathur; William L Lombardi; Ziad A Ali; Dimitri Karmpaliotis
Journal:  Eur Heart J Case Rep       Date:  2018-04-02

9.  Marking wire technique for zero-contrast percutaneous coronary interventions.

Authors:  Jerzy Sacha
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-06-19       Impact factor: 1.426

Review 10.  Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review.

Authors:  Jerzy Sacha; Marek Gierlotka; Piotr Feusette; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-06-22       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.